EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Integrative Genomic and Stem Cell Frameworks for Variant‐to‐Function Discovery in Autism Spectrum Disorder: A Narrative Review

Jalal Uddin, Randhir Singh, Chandralekha Nair, Mohamed Rahamathulla, Mohammed Muqtader Ahmed, Iqbal Hossain Nafiz, Tarig Hakim Merghani, Azza Osman Alawad, Dyumn Dwivedi, Uddalak Das

Developmental Neurobiology · 2027-01 · 87 (1)

DOI: 10.1002/dneu.70072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Developmental Neurobiology, online erschienen am 14.11.2026. Verfasst von Jalal Uddin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Asir, Saudi Arabia. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Genomics, Pluripotent Stem Cells. Die Arbeit nennt 193 Literaturangaben. Gefördert von: Department of Biotechnology, Council of Scientific and Industrial Research, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition shaped by de novo protein‐truncating variants, inherited missense substitutions, recurrent copy number variations (CNVs), and distributed polygenic risk. These alterations converge on a limited set of neurobiological processes, including synaptic refinement, excitation‐to‐inhibition balance, chromatin state regulation, and glial‐mediated neuroimmune signaling. Experimental paradigms now exist for systematic variant‐to‐function interrogation through CRISPR‐engineered isogenic human pluripotent stem‐cell libraries incorporating Cas9 nucleases, programmable transcriptional modulators (dCas9‐KRAB and dCas9‐VP64), base editors, and prime editing systems. Coupled with single‐cell multi‐omic platforms such as Perturb‐seq, scATAC‐seq, and CITE‐seq, and with circuit‐level phenotyping through multielectrode arrays, calcium imaging, and quantitative morphometry, these systems resolve ASD‐relevant cellular states at single‐cell and cell‐type‐specific resolution. In this narrative review, we distinguish deliberately between what these platforms have already established and what remains proposed. To date, a small number of studies constitute the demonstrated evidence base: in vivo Perturb‐seq of 35 ASD/neurodevelopmental risk genes in mouse cortex, mosaic knockout of ASD genes in human cortical organoids, the CHOOSE organoid screen of 36 risk genes, assembloid CRISPR screening of 425 neurodevelopmental‐disorder risk genes, a 63‐line mouse embryonic stem‐cell CNV resource, and a CRISPRi screen of 102 ASD risk genes in human induced pluripotent stem‐cell (iPSC)‐derived microglia implicating ADNP in synaptic pruning. We summarized these in a dedicated comparison table. Against this, integration of polygenic and noncoding architecture, causal‐inference frameworks, such as Mendelian randomization and do‐calculus, and cross‐laboratory reproducibility, remain aspirational rather than realized. We therefore frame the field's principal near‐term requirement not as further gene discovery but as harmonized protocols, shared reference lines, arrayed validation capacity, and interpretable statistical frameworks capable of converting perturbation atlases into causal mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderGenomicsPluripotent Stem CellsHumansAnimals

Stichwörter der Autor:innen

cross‐laboratory reproducibilityisogenic allelic seriesneural lineage specificationpooled perturbation screeningregulatory variant prioritization

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Asir, Saudi Arabia.
  • School of Biotechnology (SBT), Jawaharlal Nehru University (JNU), New Delhi, India.
  • Centre for Multidisciplinary Research in Health Science (MACH), Università degli Studi di Milano Statale, Milano, Italy.
  • Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
  • Department of Chemical Engineering, Bangladesh University of Engineering & Technology, Dhaka, Bangladesh.

Förderung

  • Department of Biotechnology
  • Council of Scientific and Industrial Research
  • Indian Council of Medical Research
  • Department of Biotechnology, Government of West Bengal
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Uddin, J., Singh, R., Nair, C., Rahamathulla, M., Ahmed, M. M., Nafiz, I. H., Merghani, T. H., Alawad, A. O., Dwivedi, D., & Das, U. (2027). Integrative Genomic and Stem Cell Frameworks for Variant‐to‐Function Discovery in Autism Spectrum Disorder: A Narrative Review. Developmental Neurobiology, 87(1). https://doi.org/10.1002/dneu.70072

Vancouver

Uddin J, Singh R, Nair C, Rahamathulla M, Ahmed MM, Nafiz IH, et al. Integrative Genomic and Stem Cell Frameworks for Variant‐to‐Function Discovery in Autism Spectrum Disorder: A Narrative Review. Developmental Neurobiology. 2027;87(1). doi:10.1002/dneu.70072

BibTeX
@article{Uddin2027,
  author = {Uddin, Jalal and Singh, Randhir and Nair, Chandralekha and Rahamathulla, Mohamed and Ahmed, Mohammed Muqtader and Nafiz, Iqbal Hossain and Merghani, Tarig Hakim and Alawad, Azza Osman and Dwivedi, Dyumn and Das, Uddalak},
  title = {Integrative Genomic and Stem Cell Frameworks for Variant‐to‐Function Discovery in Autism Spectrum Disorder: A Narrative Review},
  journal = {Developmental Neurobiology},
  year = {2027},
  volume = {87},
  number = {1},
  doi = {10.1002/dneu.70072}
}
Kostenlos starten →